切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2022, Vol. 08 ›› Issue (06) : 356 -360. doi: 10.3877/cma.j.issn.2095-9141.2022.06.008

临床研究

全身免疫炎症指数对急性颅脑损伤患者早期预后的预测价值
闫肃1, 卢博1,(), 李茂琴1   
  1. 1. 221009 江苏徐州,徐州市中心医院重症医学科
  • 收稿日期:2022-07-22 出版日期:2022-12-15
  • 通信作者: 卢博

Predictive value of systemic immune-inflammation index on early prognosis of patients with acute traumatic brain injury

Su Yan1, Bo Lu1,(), Maoqin Li1   

  1. 1. Department of Critical Care Medicine, Xuzhou Central Hospital, Xuzhou 221009, China
  • Received:2022-07-22 Published:2022-12-15
  • Corresponding author: Bo Lu
引用本文:

闫肃, 卢博, 李茂琴. 全身免疫炎症指数对急性颅脑损伤患者早期预后的预测价值[J]. 中华神经创伤外科电子杂志, 2022, 08(06): 356-360.

Su Yan, Bo Lu, Maoqin Li. Predictive value of systemic immune-inflammation index on early prognosis of patients with acute traumatic brain injury[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2022, 08(06): 356-360.

目的

探讨全身免疫炎症指数(SII)对急性颅脑损伤(TBI)患者早期预后的预测价值。

方法

选取徐州市中心医院重症医学科自2018年1月至2021年12月收治的急性TBI患者为研究对象,收集所有患者的临床资料、血液检测指标,计算SII。随访30 d,根据GOS评分将患者分为预后良好组(GOS 4~5分)和预后不良组(GOS 1~3分)。采用单因素和多因素Logistic回归分析急性TBI患者预后不良的独立危险因素,绘制受试者工作特征(ROC)曲线计算曲线下面积(AUC),分析SII对急性TBI患者预后的预测价值,计算SII的最佳截断值,将患者分为高数值组和低数值组,并评估30 d的死亡风险。

结果

共纳入164例急性TBI患者,预后良好组84例(51.2%),预后不良组80例(48.8%)。2组患者的年龄、性别、平均动脉压、心率、血红蛋白、白细胞计数、中性粒细胞计数、单核细胞计数、血小板计数和单核细胞/淋巴细胞比值比较差异均无统计学意义(均P>0.05);淋巴细胞计数、中性粒细胞/淋巴细胞比值(NLR)、血小板与淋巴细胞比值、系统性炎症反应指数(SIRI)、SII比较差异具有统计学意义(均P<0.05)。预后不良组SII值明显高于预后良好组,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,NLR和SII是急性TBI患者预后不良的独立危险因素(P<0.05)。ROC曲线分析结果显示SII预测预后不良的AUC为0.925(95%CI:0.874~0.960),敏感度87.50%、特异度82.14%,预测价值优于NLR。SII的最佳截断值为15.95,SII>15.95组的死亡率(39.5%)高于SII≤15.95组(6.4%),差异具有统计学意义(相对危险度为1.547,95%CI:1.292~1.854)。

结论

SII与急性TBI患者的早期不良预后和死亡风险密切相关,SII水平越高,患者短期预后越差,死亡风险越高,SII对急性TBI患者短期不良结局有较高的预测价值。

Objective

To investigate the predictive value of systemic immune-inflammation index (SII) on the early prognosis of patients with acute traumatic brain injury (TBI).

Methods

Patients with acute TBI admitted to Critical Care Medicine Department of Xuzhou Central Hospital from January 2018 to December 2021 were selected as the research objects, and the clinical data, blood test indexes were collected and SII was calculated. Patients were followed up for 30 d and divided into good prognosis group (GOS 4-5) and poor prognosis group (GOS 1-3) according to GOS score. Independent risk factors for poor prognosis in patients with acute TBI were analysed using univariate and multi-factor Logistic regression, and the area under the curve (AUC) was calculated by plotting the subject operating characteristic (ROC) curve. The predictive value of SII on the prognosis of patients with acute TBI was analyzed. The optimal cut-off value of SII was calculated and divided into high and low value groups to assess the 30 d risk of death in both groups.

Results

A total of 164 patients with acute TBI were included, 84 (51.2%) in the good prognosis group and 80 (48.8%) in the poor prognosis group. There were no significant differences in age, sex, mean arterial pressure, heart rate, hemoglobin, leukocyte count, neutrophil count, monocyte count, platelet count and MLR between the good prognosis group and the poor prognosis group (all P>0.05); There were significant differences in lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet to lymphocyteratio ratio, systemic inflammation response index (SIRI) and SII among the groups (all P<0.05).The SII values were significantly higher in the poor prognosis group than in the good prognosis group, with a statistically significant difference (P<0.01). Multi-factor Logistic regression analysis showed that SII was an independent risk factor for poor prognosis in patients with acute TBI (OR=1.275, 95%CI: 1.123-1.448, P<0.01). ROC curve analysis showed that SII predicted poor prognosis with an AUC of 0.925 (95%CI: 0.874-0.960) , sensitivity 87.50% and specificity 82.14%, and its predictive value was better than that of NLR. The optimal cut-off value for SII was 15.95, with a statistically significant higher mortality in SII>15.95 group (39.5%) than in SII≤15.95 group (6.4%) (relative risk 1.547, 95%CI: 1.292-1.854).

Conclusion

SII is closely associated with early poor prognosis and mortality risk in patients with acute TBI. The higher the level of SII, the worse the short-term prognosis of patients and the higher the risk of death, and SII has a high predictive value for short-term adverse outcomes in patients with acute TBI.

表1 预后良好组与预后不良组患者的临床资料比较
表2 急性颅脑损伤患者预后影响因素的多因素Logistic回归分析
图1 NLR与SII预测急性颅脑损伤患者预后的受试者工作特征曲线比较NLR:中性粒细胞/淋巴细胞比值;SII:全身免疫炎症指数
表3 NLR、SII对颅脑外伤患者预后的预测价值
表4 SII截断值分组对急性颅脑损伤患者30 d死亡风险评估
[1]
Shahim P, Zetterberg H. Neurochemical markers of traumatic brain injury: relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction[J]. Biol Psychiatry, 2022, 91(5): 405-412.
[2]
林洁,何明莲,邹永杰, 等. 无创脑水肿动态监测仪对急性脑损伤诊断价值的Meta分析[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(3): 132-138.
[3]
王玉荣,郑庆斌,韦广发, 等. 中性粒细胞淋巴细胞比值对术后并发颅内感染患者的预测价值[J]. 中华神经创伤外科电子杂志, 2019, 5(5): 265-268.
[4]
Bittoni A, Pecci F, Mentrasti G, et al. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer[J]. Ann Transl Med, 2021, 9(3): 251.
[5]
Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease[J]. Eur J Clin Invest, 2020, 50(5): e13230.
[6]
Geraghty JR, Lung TJ, Hirsch Y, et al. Systemic immune-inflammation index predicts delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J]. Neurosurgery, 2021, 89(6): 1071-1079.
[7]
Defort P, Retkowska-Tomaszewska N, Kot M, et al. Inflammatory predictors of prognosis in patients with traumatic cerebral haemorrhage: retrospective study[J]. J Clin Med, 2022, 11(3): 705.
[8]
Firsching R, Rickels E, Mauer UM, et al. Guidelines for the treatment of head injury in adults[J]. J Neurol Surg A Cent Eur Neurosurg, 2017, 78(5): 478-487.
[9]
McMillan T, Wilson L, Ponsford J, et al. The Glasgow Outcome Scale - 40 years of application and refinement[J]. Nat Rev Neurol, 2016, 12(8): 477-485.
[10]
齐洪武,刘岩松,曾维俊, 等. 儿童创伤性脑损伤的研究进展[J]. 中华神经创伤外科电子杂志, 2022, 8(2): 121-124.
[11]
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222.
[12]
Hou D, Wang C, Luo Y, et al. Systemic immune-inflammation index (SII) but not platelet-albumin-bilirubin (PALBI) grade is associated with severity of acute ischemic stroke (AIS)[J]. Int J Neurosci, 2021, 131(12): 1203-1208.
[13]
Yun S, Yi HJ, Lee DH, et al. Systemic inflammation response index and systemic immune-inflammation index for predicting the prognosis of patients with aneurysmal subarachnoid hemorrhage[J]. J Stroke Cerebrovasc Dis, 2021, 30(8): 105861.
[14]
Bittoni A, Pecci F, Mentrasti G, et al. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer[J]. Ann Transl Med, 2021, 9(3): 251.
[15]
Kelesoglu S, Yilmaz Y, Elcık D, et al. Systemic immune inflammation index: a novel predictor for coronary collateral circulation[J]. Perfusion, 2022, 37(6): 605-612.
[16]
Siwicka-Gieroba D, Malodobry K, Biernawska J, et al. The neutrophil/lymphocyte count ratio predicts mortality in severe traumatic brain injury patients[J]. J Clin Med, 2019, 8(9): 1453.
[17]
Chen J, Qu X, Li Z, et al. Peak neutrophil-to-lymphocyte ratio correlates with clinical outcomes in patients with severe traumatic brain injury[J]. Neurocrit Care, 2019, 30(2): 334-339.
[18]
Denorme F, Manne BK, Portier I, et al. Platelet necrosis mediates ischemic stroke outcome in mice[J]. Blood, 2020, 135(6): 429-440.
[19]
Weng YY, Zeng TZ, Huang HH, et al. Systemic immune-inflammation index predicts 3-month functional outcome in acute ischemic stroke patients treated with intravenous thrombolysis[J]. Clin Interv Aging, 2021, 16(5): 877-886.
[20]
Dey S, Kashav R, Kaur-Kohli J, et al. Systemic immune-inflammation index predicts poor outcome after elective off-pump CABG: a retrospective, single-center study[J]. J Cardiothorac Vasc Anesth, 2021, 35(8): 2397-2404.
[1] 张旺, 曹家兴, 刘九洋, 吴高松. 全身免疫炎症指数对乳腺癌新辅助化疗疗效的预测价值及临床预测模型的构建[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 136-142.
[2] 张海燕, 俞兆儿, 王一枭, 高明明, 贾瑞喆. 胎儿脐动脉舒张末期血流缺失及脑-胎盘率降低与妊娠结局及存活儿早期预后[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(06): 665-671.
[3] 尹宏祥, 段家康, 江博文, 谈燚. 全身免疫炎症指数联合预后营养指数对接受根治性切除术的肝细胞癌的预后价值研究[J]. 中华普通外科学文献(电子版), 2023, 17(02): 93-98.
[4] 李飞翔, 段虎斌, 李晋虎, 吴昊, 王永红, 范益民. 急性颅脑损伤继发下肢静脉血栓的相关危险因素分析及预测模型构建[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 277-282.
[5] 田润发, 董金千, 刘伟明, 卢盛华, 杨梦石, 张斌, 高飞, 庄园, 葛芊芊, 徐晓健, 牛非, 刘佰运. 颅脑外伤后无瞳孔散大患者行去骨瓣减压术后的早期结果及出院死亡率的预后相关因素分析[J]. 中华神经创伤外科电子杂志, 2021, 07(02): 75-81.
[6] 郭旭东, 沈江洁. 急性颅脑损伤凝血功能变化对病情进展及预后的影响[J]. 中华神经创伤外科电子杂志, 2020, 06(06): 356-359.
[7] 黄立, 张丽娜. 急性颅脑损伤救治:不能忽视的脑血流调节功能[J]. 中华重症医学电子杂志, 2020, 06(03): 248-251.
[8] 袁永杰, 杨浩, 许安定. 急性颅脑损伤患者心电图异常情况分析[J]. 中华心脏与心律电子杂志, 2018, 06(02): 89-91.
阅读次数
全文


摘要